317 related articles for article (PubMed ID: 21890375)
1. Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.
Neumeier M; Bauer S; Brühl H; Eisinger K; Kopp A; Abke S; Walter R; Schäffler A; Buechler C
Cytokine; 2011 Dec; 56(3):573-80. PubMed ID: 21890375
[TBL] [Abstract][Full Text] [Related]
2. CXC chemokine ligand 4 (CXCL4) down-regulates CC chemokine receptor expression on human monocytes.
Schwartzkopff F; Petersen F; Grimm TA; Brandt E
Innate Immun; 2012 Feb; 18(1):124-39. PubMed ID: 21088050
[TBL] [Abstract][Full Text] [Related]
3. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
[TBL] [Abstract][Full Text] [Related]
4. Peripheral monocyte expression of the chemokine receptors CCR2, CCR5 and CXCR3 is altered at parturition in healthy women and in women with systemic lupus erythematosus.
Björkander S; Heidari-Hamedani G; Bremme K; Gunnarsson I; Holmlund U
Scand J Immunol; 2013 Mar; 77(3):200-12. PubMed ID: 23298254
[TBL] [Abstract][Full Text] [Related]
5. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages.
Kaufmann A; Salentin R; Gemsa D; Sprenger H
J Leukoc Biol; 2001 Feb; 69(2):248-52. PubMed ID: 11272275
[TBL] [Abstract][Full Text] [Related]
6. CCL3/CCR1 mediates CD14
Zhao X; Gu M; Xu X; Wen X; Yang G; Li L; Sheng P; Meng F
Osteoarthritis Cartilage; 2020 May; 28(5):613-625. PubMed ID: 32006659
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes and lipoprotein metabolism affect LPS-induced cytokine and chemokine release in primary human monocytes.
Bala M; Kopp A; Wurm S; Büchler C; Schölmerich J; Schäffler A
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):370-6. PubMed ID: 21104588
[TBL] [Abstract][Full Text] [Related]
8. Pitavastatin-induced downregulation of CCR2 and CCR5 in monocytes is associated with the arrest of cell-cycle in S phase.
Fujino M; Miura S; Matsuo Y; Tanigawa H; Kawamura A; Saku K
Atherosclerosis; 2006 Aug; 187(2):301-8. PubMed ID: 16289073
[TBL] [Abstract][Full Text] [Related]
9. Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis.
Lebre MC; Vergunst CE; Choi IY; Aarrass S; Oliveira AS; Wyant T; Horuk R; Reedquist KA; Tak PP
PLoS One; 2011; 6(7):e21772. PubMed ID: 21747955
[TBL] [Abstract][Full Text] [Related]
10. The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Res; 2008; 122(3):328-35. PubMed ID: 18048089
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE
Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
[TBL] [Abstract][Full Text] [Related]
12. Chemokine receptor expression and chemotactic responsiveness of human monocytes after influenza A virus infection.
Salentin R; Gemsa D; Sprenger H; Kaufmann A
J Leukoc Biol; 2003 Aug; 74(2):252-9. PubMed ID: 12885942
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic upregulation of CCL2 and CCL3 via histone modifications in infiltrating macrophages after peripheral nerve injury.
Kiguchi N; Kobayashi Y; Saika F; Kishioka S
Cytokine; 2013 Dec; 64(3):666-72. PubMed ID: 24135048
[TBL] [Abstract][Full Text] [Related]
14. Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial.
Loughrey BV; McGinty A; Young IS; McCance DR; Powell LA
Clin Endocrinol (Oxf); 2013 Dec; 79(6):800-6. PubMed ID: 23170936
[TBL] [Abstract][Full Text] [Related]
15. Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol.
Blednov YA; Bergeson SE; Walker D; Ferreira VM; Kuziel WA; Harris RA
Behav Brain Res; 2005 Nov; 165(1):110-25. PubMed ID: 16105698
[TBL] [Abstract][Full Text] [Related]
16. Hyperocclusion up-regulates CCL3 expression in CCL2- and CCR2-deficient mice.
Tsutsumi T; Kajiya H; Goto KT; Takahashi Y; Okabe K
J Dent Res; 2013 Jan; 92(1):65-70. PubMed ID: 23143790
[TBL] [Abstract][Full Text] [Related]
17. Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization.
Cochain C; Rodero MP; Vilar J; Récalde A; Richart AL; Loinard C; Zouggari Y; Guérin C; Duriez M; Combadière B; Poupel L; Lévy BI; Mallat Z; Combadière C; Silvestre JS
Cardiovasc Res; 2010 Oct; 88(1):186-95. PubMed ID: 20501509
[TBL] [Abstract][Full Text] [Related]
18. Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines.
Zhu K; Shen Q; Ulrich M; Zheng M
Chin Med J (Engl); 2000 Dec; 113(12):1124-8. PubMed ID: 11776150
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts.
Rüster M; Sperschneider H; Fünfstück R; Stein G; Gröne HJ
Clin Nephrol; 2004 Jan; 61(1):30-9. PubMed ID: 14964455
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
